tablet manufacturing Haridwar

Price 10000.0 INR/ Number

Get a Price/Quote

About tablet manufacturing Haridwar

Monark Biocare is one of Indias leading pharmaceutical companies, offering reliable and high-quality third-party manufacturing services to clients across the Haridwar, Uttarakhand. With our modern production facilities, experienced team, and WHO-GMP certified units, we ensure that every product manufactured under our name meets global quality standards and delivers proven therapeutic results.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Analgesic & Anti-inflammatory Drugs - Nsaids Category

Ceftazidime 250mg Injection

Price 84.45 INR / Vial

Minimum Order Quantity : 100

Life Span : 24 month

Brand Name : Avzid250

Ingredients : Ceftazidime 250mg Injection is a sterile powder vial of the thirdgeneration cephalosporin antibiotic ceftazidime for IM/IV reconstitution. Compared to higher strengths, the 250mg vial targets uncomplicated urinary tract infections (cystitis) caused by susceptible E. coli, Klebsiella, and P. mirabilis, with excellent Gramnegative penetration while minimizing dosing in mild cases.

Packaging Type : Single VIAL

Get a Price/Quote

Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet

Price 1368.75 INR / Number

Minimum Order Quantity : 100

Life Span : 24 Month

Brand Name : GLIMLASEPG2

Ingredients : Metformin (SR) 500 mg + Pioglitazone HCl 15 mg + Glimepiride 2 mg Bilayered Tablet combines sustainedrelease metformin (hepatic glucose suppression), pioglitazone (PPAR agonist improving insulin sensitivity/adipocyte differentiation), and glimepiride (sulfonylurea stimulating insulin secretion) for comprehensive type 2 diabetes management. Triple therapy targets insulin resistance, betacell dysfunction, and hepatic gluconeogenesis, achieving HbA1c reductions of 2.22.8% in patients uncontrolled on dual therapy; pioglitazone provides additional benefits in dyslipidemia (TG 15%, HDL 10%) and atherosclerosis regression. Adults: 1 tablet once daily with meals; side effects include hypoglycemia (1520%), weight gain/edema (pioglitazone), GI upset (less with SR), HF risk (monitor NYHA Class I/II only); contraindicated in DKA, eGFR<30, bladder cancer history; check LFTs, echo periodically.

Packaging Type : 10*15 Blister

Get a Price/Quote